Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2840657 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Neuregulin 1 (NRG1) (AA 198-229), (Center) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 198-229, Center
- Antibody clone number
- RB01275-01276
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references Deciphering the luteal transcriptome: potential mechanisms mediating stage-specific luteolytic response of the corpus luteum to prostaglandin F₂α.
Segregation of receptor and ligand regulates activation of epithelial growth factor receptor.
Neuregulin-1 enhances motility and migration of human astrocytic glioma cells.
Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.
Mondal M, Schilling B, Folger J, Steibel JP, Buchnick H, Zalman Y, Ireland JJ, Meidan R, Smith GW
Physiological genomics 2011 Apr 27;43(8):447-56
Physiological genomics 2011 Apr 27;43(8):447-56
Segregation of receptor and ligand regulates activation of epithelial growth factor receptor.
Vermeer PD, Einwalter LA, Moninger TO, Rokhlina T, Kern JA, Zabner J, Welsh MJ
Nature 2003 Mar 20;422(6929):322-6
Nature 2003 Mar 20;422(6929):322-6
Neuregulin-1 enhances motility and migration of human astrocytic glioma cells.
Ritch PA, Carroll SL, Sontheimer H
The Journal of biological chemistry 2003 Jun 6;278(23):20971-8
The Journal of biological chemistry 2003 Jun 6;278(23):20971-8
Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.
Atlas E, Cardillo M, Mehmi I, Zahedkargaran H, Tang C, Lupu R
Molecular cancer research : MCR 2003 Jan;1(3):165-75
Molecular cancer research : MCR 2003 Jan;1(3):165-75
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS